Translational cancer research impact factor
Translational Cancer Research Journal description of ICL repair and its impact on cancer development and treatment is very important. was to investigate the use of hypoxiainducible factorIMPACT FACTOR 3. 687. Journal Menu Special Issue Basic and Translational Research in Colorectal Cancer Print Special Issue Flyer; Special Issue Editors Special Issue Information Translational research has led to significant benefits in CRC screening and patient management, and precision medicine is fast becoming the aim of scientific translational cancer research impact factor
Translational Research delivers original investigations in the broad fields of laboratory, clinical, and public health research. Interdisciplinary and crossdisciplinary in scope, it keeps readers uptodate on significant biomedical research from all subspecialties of medicine.
Translational cancer research impact factor free
The focus of TCR is original, peerreviewed, sciencebased research that successfully advances clinical medicine toward the goal of improving patients' quality of life. The editors and an international advisory group of scientists and clinicianscientists as well as other experts will hold TCR articles to the highquality standards.
Mar 12, 2019 Translational Lung Cancer Research (TLCR, Transl Lung Cancer Res, Print ISSN; Online ISSN ) is an international, peerreviewed, openaccess journal, which was founded in March 2012. TLCR is indexed by Science Citation Index Expanded (SCIE), PubMedPubMed Central, Scopus and the Chemical Abstracts Service (CAS) Databases.
Oncology Translational Research is an International journal devoted to fostering research investigations which bridge the laboratory and clinical settings.
Advertisements. The journal covers innovative basic, clinical and translational cancer research studies that bridge the laboratory and the clinic. Cancer Translational Medicine is especially interested in cancer risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and experimental therapeutics in the field
Translational Medicine is an international Open Access, peerreviewed, academic journal providing an opportunity to share the information among the medical scientists and researchers. This journal includes a wide range of Translational Research themes related cancer, Kidney, cardiovascular, Neuroscience, Gastrointestinal and liver diseases.
Publications in this journal. Being the most common tumor of the urinary tract, bladder cancer (BC) has a prolonged nature that like many chronic disease requiring careful and invasive longterm surveillance. Among cancers, BC has the highest costs per patient making it an economic
Translational Cancer Research. TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention,
Rating: 4.35 / Views: 974